Chularat Hospital Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jedsada Chokdamrongsuk

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2.2yrs
Gemiddelde ambtstermijn bestuur	20.8yrs

Recente managementupdates

Recent updates

CEO

Jedsada Chokdamrongsuk (66 yo)

less than a year

Tenure

Dr. Jedsada Chokdamrongsuk is CEO & Director of Chularat Hospital Public Company Limited from November 14, 2023. He serves as Independent Chairman at Master Style Public Company Limited since 2020. He hold...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Suchai Laoveerawat	Deputy Medical Director & Executive Director	no data	฿540.00k	geen gegevens
Yudthana Sanguansakdikosol	Deputy Chief Executive Officer	no data	geen gegevens	geen gegevens
Chutima Pincharean	Deputy Chief Executive Officer	no data	geen gegevens	geen gegevens
Jedsada Chokdamrongsuk	CEO & Director	less than a year	geen gegevens	geen gegevens
Suppachoke Rojcheewin	Chief Financial Officer	2.2yrs	geen gegevens	geen gegevens
Rasika Bangpong	Chief Accounting Manager	2.2yrs	geen gegevens	geen gegevens
Wandee Pitsanuvanavech	Deputy CEO	12yrs	geen gegevens	geen gegevens

2.2yrs

Gemiddelde duur

67.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CHG wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Suchai Laoveerawat	Deputy Medical Director & Executive Director	20.8yrs	฿540.00k	geen gegevens
Jedsada Chokdamrongsuk	CEO & Director	less than a year	geen gegevens	geen gegevens
Manit Jeeradit	Independent Director	12.8yrs	฿760.00k	geen gegevens
Kriengsak Plussind	Chairman	20.8yrs	฿685.00k	10.54% THB 3.4b
Apirum Panyapol	Non-Executive Director	20.8yrs	฿550.00k	10.25% THB 3.3b
Wichit Siritattamrong	Non-Executive Director	20.8yrs	฿525.00k	geen gegevens
Kobkul Panyapol	Non-Executive Director	20.8yrs	฿525.00k	8.04% THB 2.6b
Yanyong Amornpitakkul	Non-Executive Director	20.8yrs	฿585.00k	geen gegevens
Kannikar Plussind	Non-Executive Director	20.8yrs	฿525.00k	18.13% THB 5.8b
Somyos Yan-Ubol	Independent Director	12.8yrs	฿725.00k	geen gegevens
Pinit Kullavanijaya	Independent Director	12.8yrs	฿600.00k	geen gegevens
Santhat Sanguandikul	Independent Director	2.5yrs	฿555.00k	geen gegevens

20.8yrs

Gemiddelde duur

69yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CHG zijn ervaren en ervaren (gemiddelde ambtstermijn van 20.8 jaar).

Chularat Hospital Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 26, 2024

Chularat Hospital Public Company Limited Approves Appointment of the Directors of Sub-Committees

Less than half of directors are independent

Chularat Hospital Public Company Limited Appoints Wandee Pisanuvanavech as Deputy Chief Executive Officer

Chularat Hospital Public Company Limited Announces Executive Changes

Chularat Hospital Public Company Limited Appoints Santhat Sanguandikul as Member of the Audit Committee

Recent updates

First half dividend of ฿0.02 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2024 to 30 June 2024, Payable on September 13, 2024

First quarter 2024 earnings released: EPS: ฿0.024 (vs ฿0.022 in 1Q 2023)

Now 22% overvalued

Now 21% overvalued

Now 21% overvalued

Final dividend of ฿0.05 announced

Full year 2023 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 26, 2024

Chularat Hospital Public Company Limited Approves Appointment of the Directors of Sub-Committees

Third quarter 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chularat Hospital Public Company Limited Approves an Interim Dividend for the Six-Month Period Ended 30 June 2023, Payable on 8 September 2023

Price target decreased by 7.2% to ฿3.85

First quarter 2023 earnings: EPS misses analyst expectations

Upcoming dividend of ฿0.075 per share at 4.4% yield

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Chularat Hospital Public Company Limited Appoints Wandee Pisanuvanavech as Deputy Chief Executive Officer

Chularat Hospital Public Company Limited Announces Executive Changes

Upcoming dividend of ฿0.085 per share

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2022 to 30 June 2022, Payable on September 9, 2022

Chularat Hospital Public Company Limited Appoints Santhat Sanguandikul as Member of the Audit Committee

Consensus EPS estimates increase by 18%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ฿0.17 per share

Less than half of directors are independent

Consensus EPS estimates increase by 27%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Chularat Hospital Public Company Limited Proposes Interim Dividend, Payable on or Before May 20, 2022

Third quarter 2021 earnings released: EPS ฿0.14 (vs ฿0.026 in 3Q 2020)

Upcoming dividend of ฿0.03 per share

Consensus forecasts updated

Price target increased to ฿4.27

Chularat Hospital Public Company Limited (SET:CHG) acquired additional 10% stake in Ruampat Mae Sot International Company.

Consensus EPS estimates increase to ฿0.10

First quarter 2021 earnings released: EPS ฿0.023 (vs ฿0.017 in 1Q 2020)

Upcoming dividend of ฿0.03 per share

New 90-day high: ฿2.78

Full year 2020 earnings released: EPS ฿0.08 (vs ฿0.064 in FY 2019)

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 23, 2021

New 90-day high: ฿2.74

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS ฿0.026

Upcoming Dividend of ฿0.02 Per Share

First half earnings released

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd